AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Siliq market report points to faster growth in North America
AGP
The Business Research Company says the Siliq market is expanding on rising plaque psoriasis cases, broader biologics use and growing demand for personalized treatment.
Cell dissociation market seen reaching $0.78B by 2030
AGP
The global cell dissociation market is forecast to grow from $0.48 billion in 2026 to $0.78 billion by 2030 as demand rises in cell-based research, single-cell genomics and cell therapy.
Cell expansion market seen reaching $69.42 billion by 2030
AGP
The Business Research Company projects the cell expansion market will grow from $37.54 billion in 2026 to $69.42 billion by 2030, driven by demand for cell and gene therapies, biologics manufacturing and regenerative medicine.
Finance Magnates names 2026 awards winners across trading and fintech
AGP
Finance Magnates announced the winners of its 2026 Awards at a gala in Limassol, Cyprus, on Nov. 6, recognizing brokers, fintech firms, payments providers and CEOs across B2C and B2B categories.
Cell therapy technologies market seen reaching $11.35 billion by 2030
AGP
The cell therapy technologies market is projected to grow from $5.67 billion in 2025 to $11.35 billion by 2030, according to The Business Research Company.
Cell Viability Assays Market Seen Reaching $2.72 Billion by 2030
AGP
The global cell viability assays market reached $1.73 billion in 2025 and is projected to hit $2.72 billion by 2030, according to The Business Research Company.
Lipsia drops nu-disco single Do It Right in comeback push
AGP
Angolan singer Lipsia has released “Do It Right,” a nu-disco single that follows her earlier track “Angel” and marks another step in her comeback.
Cell and gene therapy manufacturing services market seen doubling by 2030
AGP
The Business Research Company says the global cell and gene therapy manufacturing services market will rise from $9.44 billion in 2025 to $21.05 billion by 2030, led by demand for outsourced production and larger-scale advanced therapy capacity….
Cell processing technologies market seen reaching $9.24B by 2030
AGP
The Business Research Company says the cell processing technologies market will grow from $4.89 billion in 2025 to $9.24 billion by 2030, supported by cell therapy commercialization, automation and personalized medicine demand.
Cell-free DNA extraction market seen reaching $2.74 billion by 2030
AGP
The cell-free DNA isolation and extraction market is projected to rise from $2.05 billion in 2025 to $2.19 billion in 2026, with growth tied to liquid biopsy, prenatal screening and cancer diagnostics.
Cannabis extract market seen reaching $30.83 billion by 2030
AGP
The Business Research Company says the cannabis extract market will grow from $12.6 billion in 2025 to $30.83 billion by 2030, driven by legalization, wellness demand and broader pharmaceutical use. North America held the biggest share in 2025,…
Cannabis testing market seen doubling to $8.72 billion by 2030
AGP
The Business Research Company says the cannabis testing market will grow from $4.26 billion in 2026 to $8.72 billion by 2030, driven by legalization, tighter regulation and demand for faster, more accurate testing.
Omisirge market seen growing as personalized cell therapy demand rises
AGP
The Business Research Company says the Omisirge market is set for continued growth through 2026 to 2035, driven by rising blood cancer cases, broader use of allogeneic stem cell transplants and demand for personalized therapies.
Rainforest Trust pledges $50 million for conservation across Commonwealth countries
AGP
Rainforest Trust will commit $50 million to new conservation projects in low- and middle-income Commonwealth nations across Latin America and the Caribbean, Africa, and the Asia-Pacific from 2026 through 2030. The pledge, announced at the…
Carbon dioxide laser market seen reaching $5.73 billion by 2030
AGP
The Business Research Company says the global carbon dioxide laser market reached $4.18 billion in 2025 and is projected to hit $5.73 billion by 2030, driven by industrial, medical and manufacturing demand.
Prolia and Ranmark market growth tied to osteoporosis and bone cancer demand
AGP
The Prolia or Ranmark market is expanding on rising osteoporosis and bone metastasis cases, an aging population and broader use of biologic therapies.
Ocrevus market report sees growth on rising MS cases and personalized care
AGP
The Business Research Company’s new report projects continued expansion in the global Ocrevus market through 2035, driven by rising multiple sclerosis diagnoses, broader infusion access and growing interest in personalized treatment.
Pegasys Copegus combination pack market seen growing at slower pace through 2035
AGP
The Pegasys Copegus combination pack market is expected to keep expanding through 2035, but at a slower pace as newer antivirals take share.
Praxbind market grows on bleeding risk, surgery demand and aging populations
AGP
The Praxbind market is being shaped by rising anticoagulant use, more emergency surgery and a larger elderly population, according to The Business Research Company’s 2026 global report.
Phesgo market forecast points to steady growth through 2035
AGP
The Business Research Company says the global Phesgo market is set to expand as breast cancer diagnoses rise and demand grows for subcutaneous, personalized oncology treatments.
Sign up for:
Africa News Guide
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.